Lexicon Pharmaceuticals | LXRX - Stock


Lexicon Pharmaceuticals reported $168K in Stock for its fiscal quarter ending in June of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Akebia Therapeutics USD 15.61M 3.03M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Halozyme Therapeutics USD 176.48M 9.32M Dec/2025
Illumina USD 564M 26M Dec/2025
Insmed USD 132.07M 11.1M Dec/2025
J&J USD 14.19B 45M Dec/2025
Lexicon Pharmaceuticals USD 168K 33K Jun/2025
MacroGenics USD 7.91M 840K Dec/2025
MannKind USD 35.31M 8.34M Dec/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Novartis USD 6.42B 114M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
United Therapeutics USD 183.1M 6.6M Dec/2025
Vanda Pharmaceuticals USD 1.85M 190K Dec/2025